-
Donanemab, sold
under the
brand name Kisunla, is a
monoclonal antibody used for the
treatment of Alzheimer's disease.
Donanemab was
developed by Eli Lilly...
-
December 2024.
Donanemab, sold
under the
brand name Kisunla, is a
monoclonal antibody used for the
treatment of Alzheimer's disease.
Donanemab was developed...
-
domitroban (INN)
domoprednate (INN)
domoxin (INN)
domperidone (INN)
donanemab-azbt
donanemab (INN)
donepezil (INN)
donetidine (INN)
donislecel (USAN) Donnatal...
-
Health and Care
Excellence (NICE)
announces that the Alzheimer's drug
Donanemab will not be made
available on the NHS in
England because of its cost and...
-
course by
targeting amyloid beta with
immunotherapy medications such as
donanemab, aducanumab, and lecanemab.
Aducanumab was
approved by the US Food and...
-
treatment of fibromyalgia, neuropathy,
chronic pain and osteoarthritis.
Donanemab, sold
under the
brand name Kisunla, is a
monoclonal antibody used for...
-
Memantine N06DX02
Ginkgo folium N06DX03
Aducanumab N06DX04
Lecanemab N06DX05
Donanemab N06DX30
Combinations "ATC (Anatomical
Therapeutic Chemical classification...
-
sclerosis Domagrozumab mab
humanized GDF-8
Duchenne muscular dystrophy Donanemab Kisunla mab
humanized Amyloid beta Y Alzheimer's
disease Dorlimomab aritox...
- Bapineuzumab, Solanezumab, Gautenerumab, Crenezumab, Aducanemab,
Lecanemab and
Donanemab. Bapineuzumab, a
humanized anti-Aβ mAb, is
directed against the N-terminus...
- low-income-affected people. 3 May Drug
company Eli
Lilly reports that
donanemab can slow the pace of Alzheimer's
disease by 35%,
following a
Phase 3 study...
